Bellicum Pharmaceuticals Inc Asset Turnover Ratio (BLCM), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bellicum Pharmaceuticals Inc   (BLCM)
 

Bellicum Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Bellicum Pharmaceuticals Inc asset turnover ratio, the ability of Bellicum Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.11 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as BLCM's position remain challenging.

Within sector only one company achieved higher asset turnover ratio in the third quarter 2023. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 65, from total ranking in the second quarter 2023 at 3270.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLCM Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -78.09 % -76.14 % -60.26 % -51.52 % 39.82 %
Y / Y Revenue Change -0.89 % -76.92 % -7.14 % -1.57 % -79.8 %
Asset Turnover Ratio (TTM) 0.11 0.08 0.06 0.05 0.04
BLCM's Total Ranking # 65 # 3270 # 3289 # 3475 # 2752
Seq. Asset Change -21.53 % -49.4 % -27.55 % -23.85 % -14.54 %
Seq. Revenue Change 33300 % -76.92 % -97.4 % -50.54 % 7676.92 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 7
Overall Market # 65

Asset Turnover Ratio Statistics
High Average Low
257.39 18.18 0.55
(Sep 30 2023)   (Dec 31 2017)




BLCM Company Profile • Back to BLCM Efficiency Comparisons • Compare BLCM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Scientific Industries Inc   0.61 $ 11.043  Millions$ 18.161  Millions
Jin Medical International Ltd  0.60 $ 19.821  Millions$ 32.903  Millions
Biocryst Pharmaceuticals Inc   0.60 $ 317.556  Millions$ 528.137  Millions
Societal Cdmo Inc   0.60 $ 91.195  Millions$ 151.912  Millions
Teladoc Health Inc   0.60 $ 2,579.597  Millions$ 4,324.720  Millions
Incyte Corporation  0.60 $ 3,609.008  Millions$ 6,058.776  Millions
Eli Lilly And Company  0.60 $ 32,072.500  Millions$ 53,845.575  Millions
Zoetis Inc   0.59 $ 8,371.000  Millions$ 14,133.500  Millions
Fennec Pharmaceuticals Inc   0.59 $ 13.052  Millions$ 22.044  Millions
Ardelyx inc   0.59 $ 134.271  Millions$ 226.917  Millions
Universe Pharmaceuticals Inc  0.59 $ 32.309  Millions$ 54.667  Millions
Sientra Inc   0.59 $ 89.269  Millions$ 151.099  Millions
Novavax inc   0.59 $ 1,049.762  Millions$ 1,785.896  Millions
Stereotaxis Inc   0.59 $ 28.835  Millions$ 49.242  Millions
Emmaus Life Sciences Inc   0.58 $ 28.460  Millions$ 48.728  Millions
Palvella Therapeutics Inc   0.58 $ 47.357  Millions$ 81.167  Millions
Intra cellular Therapies Inc   0.58 $ 420.140  Millions$ 727.051  Millions
Iqvia Holdings Inc   0.58 $ 14,855.000  Millions$ 25,772.250  Millions
Exelixis Inc   0.58 $ 1,774.473  Millions$ 3,083.556  Millions
Lemaitre Vascular Inc   0.58 $ 184.930  Millions$ 321.455  Millions
Voyager Therapeutics Inc   0.57 $ 158.398  Millions$ 276.460  Millions
10x Genomics Inc   0.57 $ 564.226  Millions$ 987.104  Millions
Acadia Healthcare Company Inc   0.57 $ 2,923.743  Millions$ 5,132.146  Millions
Caredx Inc   0.57 $ 297.139  Millions$ 521.802  Millions
Urogen Pharma Ltd   0.57 $ 76.465  Millions$ 134.392  Millions
Zimvie Inc   0.56 $ 887.759  Millions$ 1,571.470  Millions
Neuropace Inc   0.56 $ 59.466  Millions$ 105.477  Millions
Harpoon Therapeutics Inc   0.56 $ 37.341  Millions$ 66.329  Millions
Organon and Co   0.56 $ 6,150.000  Millions$ 10,927.250  Millions
Dexcom Inc   0.56 $ 3,402.300  Millions$ 6,081.125  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.